These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. Mwinga A; Hosp M; Godfrey-Faussett P; Quigley M; Mwaba P; Mugala BN; Nyirenda O; Luo N; Pobee J; Elliott AM; McAdam KP; Porter JD AIDS; 1998 Dec; 12(18):2447-57. PubMed ID: 9875583 [TBL] [Abstract][Full Text] [Related]
3. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group. Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934 [TBL] [Abstract][Full Text] [Related]
4. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Shang N; Mosimaneotsile B; Motsamai OI; Bozeman L; Davis MK; Talbot EA; Moeti TL; Moffat HJ; Kilmarx PH; Castro KG; Wells CD Lancet; 2011 May; 377(9777):1588-98. PubMed ID: 21492926 [TBL] [Abstract][Full Text] [Related]
5. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania. Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766 [TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease. Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069 [TBL] [Abstract][Full Text] [Related]
7. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Gray DM; Zar H; Cotton M Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285 [TBL] [Abstract][Full Text] [Related]
8. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. Whalen CC; Johnson JL; Okwera A; Hom DL; Huebner R; Mugyenyi P; Mugerwa RD; Ellner JJ N Engl J Med; 1997 Sep; 337(12):801-8. PubMed ID: 9295239 [TBL] [Abstract][Full Text] [Related]
9. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. Bucher HC; Griffith LE; Guyatt GH; Sudre P; Naef M; Sendi P; Battegay M AIDS; 1999 Mar; 13(4):501-7. PubMed ID: 10197379 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. Quigley MA; Mwinga A; Hosp M; Lisse I; Fuchs D; Porter JDH ; Godfrey-Faussett P AIDS; 2001 Jan; 15(2):215-22. PubMed ID: 11216930 [TBL] [Abstract][Full Text] [Related]
11. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Fitzgerald DW; Desvarieux M; Severe P; Joseph P; Johnson WD; Pape JW Lancet; 2000 Oct; 356(9240):1470-4. PubMed ID: 11081529 [TBL] [Abstract][Full Text] [Related]
12. Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis. Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Mosimaneotsile B; Motsamai OI; Shang N; Rose CE; Shepherd J AIDS; 2015 Jan; 29(3):351-9. PubMed ID: 25686683 [TBL] [Abstract][Full Text] [Related]
13. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126 [TBL] [Abstract][Full Text] [Related]
15. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A; Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337 [TBL] [Abstract][Full Text] [Related]
16. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. Grant AD; Charalambous S; Fielding KL; Day JH; Corbett EL; Chaisson RE; De Cock KM; Hayes RJ; Churchyard GJ JAMA; 2005 Jun; 293(22):2719-25. PubMed ID: 15941800 [TBL] [Abstract][Full Text] [Related]
17. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Rangaka MX; Wilkinson RJ; Boulle A; Glynn JR; Fielding K; van Cutsem G; Wilkinson KA; Goliath R; Mathee S; Goemaere E; Maartens G Lancet; 2014 Aug; 384(9944):682-90. PubMed ID: 24835842 [TBL] [Abstract][Full Text] [Related]